title: "Aging Memory Loss vs Dementia: What Depression's Hidden Impact on the Hippocampus Reveals" description: "A new USC study of 2,009 older adults reveals that depression specifically shrinks the CA23DG hippocampal subfield—distinct from Alzheimer's pathways—shedding light on what separates normal cognitive aging from dementia risk."
Depression's Hidden Fingerprint in the Memory Brain
Depression isn't just a mood disorder. It leaves a physical mark on the brain, and in older adults, that mark shows up in a very specific place. A new study published in Translational Psychiatry by researchers at the USC Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) has identified what happens when depression collides with aging memory loss vs dementia pathways—and why it matters for cognitive health in later life.
The research, involving 2,009 cognitively unimpaired adults aged 50 to 90, used high-resolution MRI scans to examine individual hippocampal subfields. The findings? Depression is specifically linked to smaller volumes in the CA23DG subfield (combining CA2, CA3, and the dentate gyrus), independent of Alzheimer's biomarkers like amyloid-beta, tau protein, and the APOE ε4 genetic variant.
This matters because it suggests depression-hippocampus pathways may be distinct from the mechanisms that drive Alzheimer's disease—a crucial distinction when we're trying to understand what is normal cognitive aging versus what signals something more serious.
What Is Normal Cognitive Aging?
Before diving into the findings, it's worth clarifying what we're talking about when we discuss cognitive aging. Normal cognitive aging involves gradual changes in processing speed, mild forgetfulness, and occasional difficulty recalling names or where you put your keys. These are typical and don't interfere significantly with daily life.
What's not normal is the progressive memory loss associated with dementia, or the structural brain changes linked to clinical depression. The new study's participants were all "cognitively unimpaired"—meaning they didn't show symptoms of dementia or significant cognitive decline. Yet even among this healthy group, those with depression showed measurable structural differences in a key memory region.
Understanding what is normal cognitive aging helps us recognize when changes cross the line into something that requires attention. This study adds a new dimension to that conversation.
The CA23DG Subfield: Why It Matters
The hippocampus isn't a single, uniform structure. It's made up of several smaller sections, or subfields, each performing different functions and responding differently to aging, depression, and neurological disease.
The CA23DG subfield, encompassing the CA2, CA3, and dentate gyrus, plays a particularly important role in retrieving memories, distinguishing between similar experiences (pattern separation), and using partial information to reconstruct more complete memories (pattern completion). When this subfield shrinks, those functions suffer.
The study found that depression was associated with smaller CA23DG volume but not with significant differences in the CA1 or subiculum. This specificity is key. It means we can't just look at total hippocampal volume anymore; doing so obscures changes concentrated in only one subfield.
As lead author Danielle Luu, PhD student at USC's Neuroscience Graduate Program, explained: "By looking closely at the individual parts of the hippocampus, we identified a specific area that may be particularly sensitive to depression in older adults."
Senior author Meredith N. Braskie, assistant professor of neurology and director of education at Stevens INI, added: "This study shows why it is important to look beyond the total size of the hippocampus. Depression was not related to smaller volume throughout the entire region. The association was concentrated in a particular set of subfields, giving us a more precise picture of how depression may relate to brain health during aging."
Independence From Alzheimer's Pathology
One of the study's most striking findings: the association between depression and CA23DG volume reduction persisted even after accounting for key Alzheimer's biomarkers. The researchers used positron emission tomography (PET) scans to measure amyloid and tau proteins, two proteins that accumulate abnormally in the brains of people with Alzheimer's disease. They also assessed whether participants carried the APOE ε4 gene variant, associated with increased Alzheimer's risk.
None of these factors significantly changed the relationship between depression and CA23DG volume. The results suggest that depression may relate to hippocampal structure through pathways that are at least partly distinct from the well-known features of Alzheimer's disease.
This finding has implications for how we think about the connection between depression and dementia risk. As Arthur W. Toga, PhD, director of Stevens INI and the Ghada Irani Chair in Neuroscience at the Keck School of Medicine, noted: "These findings reinforce the importance of considering mental health as part of the broader picture of healthy brain aging. Understanding how depression relates to specific memory systems may help researchers identify people at risk, clarify the pathways connecting depression and dementia, and ultimately guide more personalized approaches to protecting brain health."
What About Antidepressants?
Here's where things get complicated, and where caution is essential.
Within the group of participants with depression, those who reported taking antidepressant medication had smaller CA1 and CA23DG volumes than those who did not use these medications. However, the researchers cautioned that this finding does not necessarily show that antidepressants caused the differences.
Why? Because the study lacked information about how long participants had experienced depression, how severe their symptoms were before beginning treatment, or how long they had taken medication. People prescribed antidepressants may have experienced more severe or longer-lasting depression, which could itself relate to hippocampal volume.
As Luu emphasized: "In this study, we cannot separate potential effects of medication from the effects of the more severe depression that medications are prescribed to treat. Long-term studies that follow people before and after treatment will be essential for understanding these relationships. Our results should not be interpreted as a reason for anyone to change or discontinue prescribed medication."
Bottom line: Don't stop taking your antidepressants based on this study. Period.
A Diverse, Representative Cohort
The study drew data from the Health and Aging Brain Study–Health Disparities (HABS-HD), a community-based research initiative examining Alzheimer's disease risk and resilience among Hispanic, non-Hispanic Black, and non-Hispanic White older adults. This diverse population and detailed brain imaging enabled the researchers to examine depression and brain aging in a substantially larger and more representative group than many previous studies.
That diversity matters, not just for scientific rigor, but for ensuring that findings about cognitive aging apply broadly across communities that have historically been underrepresented in neuroimaging research.
Limitations and What Comes Next
The study has limitations, and the researchers acknowledge them frankly. It's cross-sectional, meaning it can't establish causality. We don't know whether depression causes hippocampal shrinkage, whether people with smaller CA23DG volumes are more prone to developing depression, or whether some third factor drives both.
Additionally, depression diagnoses and medication information were based on participant self-reports rather than medical records. Future longitudinal studies, following participants over time and examining depression history, symptom severity, medication type, dosage, and duration of treatment, will be essential for understanding these relationships.
Crucially, the findings do not establish that the observed structural differences will lead to Alzheimer's disease. Instead, they identify a specific brain region for further investigation and underscore the value of integrating mental health into research on aging and dementia.
How to Maintain Cognitive Health in Older Age
So what can we take away from this study when thinking about how to maintain cognitive health in older age?
First, mental health matters, not just for emotional well-being, but for physical brain structure. Depression leaves a measurable mark on the hippocampus, even in people who remain cognitively unimpaired. Addressing depression should be part of any comprehensive approach to cognitive health.
Second, not all memory changes are created equal. Understanding what is normal cognitive aging versus what might signal something more serious, like the structural changes linked to depression or the protein accumulations associated with Alzheimer's, can help guide decisions about when to seek evaluation and intervention.
Third, the specificity of these findings highlights the importance of personalized approaches to brain health. One size doesn't fit all, whether we're talking about treatment, prevention, or research.
For now, the best advice remains what it's always been: stay physically active, engage socially, challenge your brain with new learning, manage stress, and don't ignore depression. If you're struggling, get help. Your brain will thank you, and so will the scientists trying to figure out how all these pieces fit together.
This article draws on research published in Translational Psychiatry (DOI: 10.1038/s41398-026-04223-y) by Danielle Luu, Alicia M. Twisselmann, Victoria R. Tennant, Brandon J. Hall, Arjun Mahajan, Audrey Kim, Jamie Terner, Marylan L. Davison, Koral Wheeler, Christopher R.K. Ching, James Hall, Matthew T. Borzage, Leigh Johnson, Arthur W. Toga, Sid E. O'Bryant, Kristine Yaffe, and the HABS-HD Study Team. Funding was provided by the National Institutes of Health.
Original source: Neuroscience News (August 6, 2026)
